TPST
Tempest Therapeutics (TPST)
$82
About Tempest Therapeutics (TPST)
Tempest Therapeutics, Inc. is a clinical-stage oncology company, which engages in the development and discovery of small molecule drugs for the treatment of cancer. The company was founded in 2011 and is headquartered in Brisbane, CA.
Details
Daily high
$0.84
Daily low
$0.81
Price at open
$0.82
52 Week High
$6.00
52 Week Low
$0.70
Market cap
36.0M
Dividend yield
0.00%
Volume
395,571
Avg. volume
487,579
P/E ratio
-.54
Tempest Therapeutics News
Details
Daily high
$0.84
Daily low
$0.81
Price at open
$0.82
52 Week High
$6.00
52 Week Low
$0.70
Market cap
36.0M
Dividend yield
0.00%
Volume
395,571
Avg. volume
487,579
P/E ratio
-.54